Proton Re-Irradiation for Recurrent Head and Neck Cancer

  • End date
    Jul 2, 2023
  • participants needed
  • sponsor
    Memorial Sloan Kettering Cancer Center
Updated on 2 July 2022
primary tumor
recurrent head and neck carcinoma


The purpose of this study is to evaluate the tumor control and the side effects of using proton therapy for head and neck cancer that has come back.

Condition Head and Neck Cancer
Treatment conventionally fractionated full dose re-irradiation, hypofractionated palliative re-irradiation
Clinical Study IdentifierNCT03217188
SponsorMemorial Sloan Kettering Cancer Center
Last Modified on2 July 2022


Yes No Not Sure

Inclusion Criteria

Patient willing and able to provide written informed consent
Age ≥18 years at the time of consent
Pathologically confirmed diagnosis of a recurrent or a new primary head and neck cancer
A history of prior radiation to the head and neck (>/= 40 Gy, in 2 Gy/fraction equivalent)
The recurrent or the second primary tumor is unresectable, the patient elects against surgical resection; patients who underwent surgery who has indications for postoperative radiation therapy is also eligible
Men and women of childbearing potential must be willing to consent to using effective contraception while on treatment and for at least 3 months after treatment Note: Patient with <6 months of life expectancy will be treated with palliative QUAD shot radiotherapy and those with > 6 months of life expectancy will be treated with conventionally fractionated full dose re-irradiation approach. Additional other factors determining which patients will be treated with Quad Shot therapy rather than full dose are if the patients have poor performance status, bulky or diffuse disease, significant medical co-morbidities, and significant metastatic disease burden

Exclusion Criteria

Women who are pregnant or lactating
Inability to comply with study and/or follow-up procedures
<6 months between completion of prior RT and initiation of reirradiation using proton therapy
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note